Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic Syndromes × zanubrutinib × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Waldenstrom Macroglobulinemia 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia 2 B-cell Malignancies 2 Lymphoma, B-Cell 1

Interventions

fludarabine phosphate 87 Cyclophosphamide 77 Azacitidine 59 Whole-Body Irradiation 58 fludarabine 55 Mycophenolic Acid 54 Busulfan 53 Tacrolimus 51 Peripheral Blood Stem Cell Transplantation 41 Melphalan 40 Antilymphocyte Serum 38 Cytarabine 37 Filgrastim 36 Methotrexate 32 Granulocyte Colony-Stimulating Factor 32 Decitabine 32 Cyclosporine 31 thymoglobulin 22 Thiotepa 21 Clofarabine 21 Cord Blood Stem Cell Transplantation 19 Stem Cell Transplantation 16 Alemtuzumab 16 Rituximab 15 Sirolimus 14 sargramostim 12 Lenalidomide 12 Etoposide 11 Radiotherapy 10 venetoclax 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡